Formulating Poorly Water Soluble Drugs
3., Third Edition 2022
Springer Nature Switzerland
ISBN 978-3-030-88719-3
Standardpreis
Bibliografische Daten
eBook. PDF
3., Third Edition 2022. 2022
XII, 693 p. 280 illus., 138 illus. in color..
In englischer Sprache
Umfang: 693 S.
Verlag: Springer Nature Switzerland
ISBN: 978-3-030-88719-3
Weiterführende bibliografische Daten
Das Werk ist Teil der Reihe: AAPS Advances in the Pharmaceutical Sciences Series Biomedical and Life Sciences (R0) Biomedical and Life Sciences
Produktbeschreibung
The objective of this third edition is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist's approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound's physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at a minimum a working knowledge of each of the above mentioned facets and detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop.
Autorinnen und Autoren
Produktsicherheit
Hersteller
Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg, DE
ProductSafety@springernature.com
BÜCHER VERSANDKOSTENFREI INNERHALB DEUTSCHLANDS

